A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions
Herpes ZosterShingles
Interventions
DRUG

valacyclovir

1 gram, three times a day for seven days

DRUG

FV-100

400 mg, once daily, for seven days

DRUG

FV-100

200 mg, once daily, for seven days

DRUG

Valacyclovir placebo

three times a day, for seven days

DRUG

FV-100 placebo

once daily, for seven days

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY